Market Cap: $60.32B
Market Cap: $60.32B
Bayer AG Poised to Benefit from U.S. Defense Production Act for Herbicides In a decisive move highlighting a shift towards strengthening domestic agricultural production, President Donald Trump signs…
U.S. DPA move on glyphosate and phosphorus places strategic spotlight on Bayer AG A presidential order invoking the Defense Production Act to boost domestic supplies of elemental phosphorus and glypho…
Bayer presses $10.5 billion plan to resolve Roundup cancer litigation Bayer AG is pushing a $10.5 billion settlement package to resolve current and future U.S. lawsuits alleging its Roundup weedkiller…
Bayer moves to cap Roundup litigation with $10.5 billion settlement package Bayer AG announces a proposed $10.5 billion package to resolve current and future U.S. lawsuits that allege its Roundup weed…
Supreme Court review could redefine Roundup liability for Bayer The U.S. Supreme Court is set to hear Monsanto Co. v. Durnell on April 27, a case that could reshape how liability for glyphosate‑based…
Supreme Court to resolve Roundup preemption fight The U.S. Supreme Court is agreeing to hear Monsanto Co. v. Durnell on April 27, setting up a high-stakes test of whether federal pesticide labeling la…
Bayer’s Roundup Appeal Moves to the Supreme Court Supreme Court Takes Up Roundup Liability Fight The U.S. Supreme Court on Feb. 11 announces it will hear Monsanto Co. v. Durnell on April 27, taking di…
Market turbulence tests Bayer’s commodity, currency and funding exposure What the market swing means for Bayer’s crop science and chemical costs Global equity volatility and swings in commodities are…
Market volatility touches commodity and energy markets Global risk swings are transmitting into commodity and energy markets, testing input-cost dynamics for large agrochemical and pharmaceutical firm…
Commodities shock tightens margins for Bayer’s crop and chemical operations Volatility in commodities and credit markets is putting renewed pressure on input costs and supply-chain financing for large…
Bayer AG Positioned for Legal Victory Amid Trade Tensions Bayer AG is currently experiencing a positive shift in its stock performance following the US Supreme Court's decision to hear its appeal conc…
Bayer AG's Legal Momentum in Roundup Litigation Amid Trade Tensions Bayer AG experiences a notable uptick in share prices as the US Supreme Court agrees to hear its appeal concerning the ongoing Round…
Bayer AG Secures Legal Momentum Amidst Trade Tensions In a significant legal development, Bayer AG experiences a notable increase in its stock value following the US Supreme Court's decision to hear t…
Bayer AG Advances Gene Therapy Efforts with FDA Acceptance for Pompe Disease Treatment Bayer AG's wholly owned subsidiary, AskBio Inc., marks a pivotal moment in gene therapy development with the rece…
Bayer AG Advances Gene Therapy for Pompe Disease with IND Acceptance Bayer AG's wholly owned subsidiary, AskBio Inc., celebrates a pivotal achievement with the acceptance of its Investigational New Dr…
Bayer AG Advances Gene Therapy for Pompe Disease with IND Acceptance Bayer AG's subsidiary, AskBio Inc., marks a significant achievement in the realm of gene therapy with the recent acceptance of its…
Bayer AG's Role in the Industrial Agriculture Debate: A Critical Examination Bayer AG stands at the crossroads of modern agricultural practices and the growing criticism surrounding industrial farming…
Bayer Partners with Cradle to Enhance Drug Development Through AI Bayer AG has entered into a strategic three-year collaboration with Cradle, a company renowned for its advancements in scientific AI s…
Bayer AG Expands AI Capabilities with Strategic Partnership Bayer AG has forged a significant three-year collaboration with Cradle, a company at the forefront of scientific AI software specializing in…
Bayer AG's Strategic Focus on siRNA Therapeutics Bayer AG is making significant strides in the field of small interfering RNA (siRNA) therapeutics, positioning itself as a leader in this rapidly evolv…
Bayer AG Advances Nucleic Acid Therapeutics: A Focus on siRNA Technology Bayer AG solidifies its position as a frontrunner in the biopharmaceutical industry through its commitment to developing small…
Bayer AG Faces Scrutiny Over Glyphosate Research Integrity In recent developments, Bayer AG contends with mounting scrutiny over the integrity of academic research related to its controversial herbici…
Bayer AG and IBM’s Game-Changing Partnership in Football Analytics Bayer AG, through its collaboration with IBM, is transforming the landscape of professional football analytics. The partnership focus…
Bayer Defends Roundup Amid Legal Challenges and Regulatory Scrutiny Bayer AG's CEO Bill Anderson stands firm in defending the safety profile of Roundup, a widely used herbicide that has come under int…
Bayer AG Advances Stroke Prevention with Promising Phase 3 Study Results Bayer AG announces significant findings from its Phase 3 OCEANIC-STROKE study, evaluating asundexian, an investigational oral F…
Bayer AG Advances Stroke Prevention with Promising Phase 3 Study Results Bayer AG announces significant topline results from its Phase 3 OCEANIC-STROKE study, focusing on its investigational oral FXIa…
Bayer AG Enhances R&D Capabilities Through Advanced Data Integration Bayer AG is taking significant strides in revolutionizing its pharmaceutical and crop science research and development (R&D) operat…
Bayer AG Reports Strong Earnings Growth Amid Strategic Initiatives Bayer AG announces a significant increase in its financial performance, reporting adjusted earnings of 17 cents per American Deposita…
Bayer Expands Collaboration with Ginkgo Bioworks to Innovate Agricultural Solutions Bayer AG deepens its strategic partnership with Ginkgo Bioworks, a collaboration that commenced in 2017, with a rene…
Bayer AG Expands Agricultural Biologicals Partnership with Ginkgo Bioworks Bayer AG's ongoing collaboration with Ginkgo Bioworks signifies a progressive step in the agricultural sector as they deepen…
Bayer AG Eyes AI Innovations to Transform Healthcare Solutions Bayer AG is at the forefront of leveraging artificial intelligence (AI) to enhance its healthcare offerings. As the AI sector experiences…
Bayer AG Embraces Innovation in Radiology through Collaboration with Subtle Medical Bayer AG continues to strengthen its commitment to advancing medical imaging through its collaboration with Subtle M…
Bayer and Subtle Medical Forge Ahead in AI-Enhanced MRI Imaging Bayer AG collaborates with Subtle Medical, Inc. in a groundbreaking study that showcases the potential of artificial intelligence (AI) i…
Bayer and WHO Foundation Forge Partnership to Combat Neglected Tropical Diseases In a significant development for global health, Bayer AG collaborates with the WHO Foundation to enhance health initiat…
Bayer AG Partners with WHO Foundation to Combat Neglected Tropical Diseases Bayer AG has formalized a significant partnership with the WHO Foundation, aimed at enhancing global health initiatives, par…
Bayer AG at the Veeva Commercial Summit: Driving Innovation in Life Sciences Bayer AG is set to play a pivotal role at the upcoming Veeva Commercial Summit in Madrid, Spain, scheduled for November 5-6…
Innovative Advancements in Customer Engagement: Bayer AG at the Veeva Commercial Summit Bayer AG is set to play a pivotal role at the upcoming Veeva Commercial Summit, scheduled for November 5-6, 2025…
Bayer AG Enhances Patient Access to Essential Medication Through Strategic Partnership Bayer AG partners with Mint Pharmaceuticals Inc. to distribute ADALAT® XL® (nifedipine extended-release tablets)…
Bayer AG's Strategic Positioning in the Growing Contrast Media Injector Market Bayer AG, a global leader in life sciences, stands to benefit significantly from the anticipated growth in the contrast m…
Corteva's Strategic Restructuring: A Shift in Agriculture Dynamics Corteva Inc., a leading player in the agriculture industry, is currently assessing a significant restructuring plan aimed at separati…
Corteva's Strategic Restructuring: Implications for the Agricultural Sector Corteva Inc., a significant player in the agricultural industry, is reportedly on the brink of a major restructuring that wo…
Bayer Strengthens Radiology Innovation with New Development Centre in India Bayer AG, a leading global company in healthcare and life sciences, partners with Tata Elxsi to inaugurate the Bayer Develop…
Bayer Foundation Champions Women Entrepreneurs to Tackle Global Food Security and Health Challenges In a significant move to support women-led initiatives addressing critical global issues, the Bayer…
Bayer Foundation Champions Women Entrepreneurs Tackling Global Challenges The Bayer Foundation Women Entrepreneurs Award (BFWEA) for 2025 recognizes 15 remarkable women from diverse regions, including…
Bayer Partners with Kumquat Biosciences to Target KRAS G12D Mutations in Cancer Treatment Bayer AG has entered into a significant collaboration with Kumquat Biosciences Inc. to develop a novel KRAS G1…
Bayer and Kumquat Forge Alliance to Combat KRAS G12D Mutations in Cancer Treatment Bayer AG and Kumquat Biosciences Inc. are partnering to develop a groundbreaking KRAS G12D inhibitor, aimed at addres…
Concerns Grow Over Pesticide Liability Protection Act's Impact on Food Safety As Congress deliberates the Pesticide Liability Protection Act, significant concerns arise regarding its potential to jeop…
K36 Therapeutics Initiates Clinical Development for KTX-2001 in Partnership with Bayer K36 Therapeutics, Inc. heralds a significant advancement in cancer treatment with the U.S. Food and Drug Administ…
K36 Therapeutics Initiates Phase 1 Trial for KTX-2001 in Collaboration with Bayer K36 Therapeutics, Inc., a clinical-stage biotechnology firm, advances its mission to tackle unmet needs in cancer trea…
Bayer AG's Oncology Strategy: The Importance of Innovative Cancer Therapies Bayer AG finds itself in a rapidly evolving oncology landscape, where advancements in cancer therapies are crucial for patie…